Australia’s Health Technology Assessment system uses comparative evaluation to determine the value of medicines against a relevant comparator. Comparator selection has increasingly defaulted to the lowest cost comparator. This analysis finds that the lowest cost comparator use has become systemic, creating structural barriers to patient access. It provides a phased roadmap proposing eight actions.

Chronic obstructive pulmonary disease (COPD) is one of Australia’s most common yet most overlooked chronic diseases. This report highlights how better management of COPD can reduce preventable hospitalisations, lower mortality and curb the growing economic and societal burden. It outlines five key recommendations that could chart a new course for COPD care to deliver measurable...

Alzheimer’s disease is one of the most significant health challenges of our time, with the potential to impact millions of Australians and place a substantial strain on our health and aged care systems. This report proposes seven recommendations to achieve a future where Australians with Alzheimer’s disease live with dignity, supported by compassionate and comprehensive...